3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
5
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Stress, Psychological
1
Stomach Neoplasms
1
Stage III and IV Ovarian Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasm, Residual
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
NSCLC
1
Muscle-Invasive Bladder Carcinoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Bites and Stings
1
Interventions
Drug Therapy
3
Carboplatin
3
Surgical Procedures, Operative
2
Pemetrexed
2
Paclitaxel
2
Cisplatin
2
toripalimab
1
tislelizumab
1
surufatinib
1
osimertinib
1
lorlatinib
1
anlotinib
1
aflutinib
1
Radiotherapy
1
Radiosurgery
1
Platinum Compounds
1
Neoadjuvant Therapy
1
Diphenhydramine
1
Cryotherapy
1
Chemotherapy, Adjuvant
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
NSCLC
×
Neoadjuvant Therapy
×
Clear all
NCT07089199
2025-07-28
TitAN
Qilu Hospital of Shandong University
Phase 2
Not yet recruiting
34 enrolled